Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	At The Market Offerings [Member]	Common Stock	Common Stock At The Market Offerings [Member]	Additional Paid-In Capital	Additional Paid-In Capital At The Market Offerings [Member]	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Beginning balance at Dec. 31, 2022	$ 1,235,584		$ 9		$ 2,420,223		$ (7,461)	$ (1,177,187)
Beginning balance, shares at Dec. 31, 2022			87,103,007
Issuance of common stock		$ 1,466				$ 1,466
Issuance of common stock, shares				35,349
Contingent consideration paid, shares			567,045
Contingent consideration paid	24,126				24,126
Exercise of stock options	755				755
Exercise of stock options, shares			48,353
Vesting of restricted stock units, shares			342,025
Stock-based compensation	27,255				27,255
Other comprehensive income (loss) - unrealized gain (loss) on marketable securities	2,989						2,989
Other comprehensive income (loss) - unrealized gain on equity method investment	1,794						1,794
Net Income (Loss)	(103,126)							(103,126)
Ending balance at Mar. 31, 2023	1,190,843		$ 9		2,473,825		(2,678)	(1,280,313)
Ending balance, shares at Mar. 31, 2023			88,095,779
Beginning balance at Dec. 31, 2022	1,235,584		$ 9		2,420,223		(7,461)	(1,177,187)
Beginning balance, shares at Dec. 31, 2022			87,103,007
Other comprehensive income (loss) - unrealized gain on equity method investment	2,240
Net Income (Loss)	(349,031)
Ending balance at Sep. 30, 2023	1,037,414		$ 9		2,567,195		(3,572)	(1,526,218)
Ending balance, shares at Sep. 30, 2023			89,097,821
Beginning balance at Mar. 31, 2023	1,190,843		$ 9		2,473,825		(2,678)	(1,280,313)
Beginning balance, shares at Mar. 31, 2023			88,095,779
Exercise of stock options	465				465
Exercise of stock options, shares			30,371
Vesting of restricted stock units, shares			151,853
Issuance of shares under employee stock purchase plan	2,051				2,051
Issuance of shares under employee stock purchase plan, shares			69,631
Stock-based compensation	36,400				36,400
Other comprehensive income (loss) - unrealized gain (loss) on marketable securities	(1,482)						(1,482)
Other comprehensive income (loss) - unrealized gain on equity method investment	292						292
Net Income (Loss)	(123,681)							(123,681)
Ending balance at Jun. 30, 2023	1,104,888		$ 9		2,512,741		(3,868)	(1,403,994)
Ending balance, shares at Jun. 30, 2023			88,347,634
Issuance of common stock		14,718				14,718
Issuance of common stock, shares				405,332
Exercise of stock options	4,384				4,384
Exercise of stock options, shares			241,123
Vesting of restricted stock units, shares			103,732
Stock-based compensation	35,352				35,352
Other comprehensive income (loss) - unrealized gain (loss) on marketable securities	142						142
Other comprehensive income (loss) - unrealized gain on equity method investment	154						154
Net Income (Loss)	(122,224)							(122,224)
Ending balance at Sep. 30, 2023	1,037,414		$ 9		2,567,195		(3,572)	(1,526,218)
Ending balance, shares at Sep. 30, 2023			89,097,821
Beginning balance at Dec. 31, 2023	$ 1,050,169		$ 9		2,710,797		(2,258)	(1,658,379)
Beginning balance, shares at Dec. 31, 2023	92,997,158		92,997,158
Issuance of common stock		55,959		$ 1		55,958
Issuance of common stock, shares				2,209,938
Exercise of stock options	$ 1,958				1,958
Exercise of stock options, shares			110,734
Vesting of restricted stock units, shares			1,015,543
Stock-based compensation	34,176				34,176
Other comprehensive income (loss) - unrealized gain (loss) on marketable securities	(821)						(821)
Reclassification of other comprehensive income (loss) - equity method investment	2,132						2,132
Net Income (Loss)	(107,436)							(107,436)
Ending balance at Mar. 31, 2024	1,036,137		$ 10		2,802,889		(947)	(1,765,815)
Ending balance, shares at Mar. 31, 2024			96,333,373
Beginning balance at Dec. 31, 2023	$ 1,050,169		$ 9		2,710,797		(2,258)	(1,658,379)
Beginning balance, shares at Dec. 31, 2023	92,997,158		92,997,158
Exercise of stock options, shares	371,736
Other comprehensive income (loss) - unrealized gain on equity method investment	$ 0
Net Income (Loss)	(390,123)
Ending balance at Sep. 30, 2024	$ 962,615		$ 10		3,007,810		3,297	(2,048,502)
Ending balance, shares at Sep. 30, 2024	101,796,365		101,796,365
Beginning balance at Mar. 31, 2024	$ 1,036,137		$ 10		2,802,889		(947)	(1,765,815)
Beginning balance, shares at Mar. 31, 2024			96,333,373
Issuance of common stock		38,399				38,399
Issuance of common stock, shares				1,592,823
Exercise of stock options	1,179				1,179
Exercise of stock options, shares			79,512
Vesting of restricted stock units, shares			195,691
Issuance of shares under employee stock purchase plan	1,669				1,669
Issuance of shares under employee stock purchase plan, shares			87,751
Stock-based compensation	40,861				40,861
Other comprehensive income (loss) - unrealized gain (loss) on marketable securities	(208)						(208)
Net Income (Loss)	(146,975)							(146,975)
Ending balance at Jun. 30, 2024	971,062		$ 10		2,884,997		(1,155)	(1,912,790)
Ending balance, shares at Jun. 30, 2024			98,289,150
Issuance of common stock		$ 80,497				$ 80,497
Issuance of common stock, shares				3,201,609
Exercise of stock options	2,697				2,697
Exercise of stock options, shares			181,490
Vesting of restricted stock units, shares			124,116
Stock-based compensation	39,619				39,619
Other comprehensive income (loss) - unrealized gain (loss) on marketable securities	4,452						4,452
Other comprehensive income (loss) - unrealized gain on equity method investment	0
Net Income (Loss)	(135,712)							(135,712)
Ending balance at Sep. 30, 2024	$ 962,615		$ 10		$ 3,007,810		$ 3,297	$ (2,048,502)
Ending balance, shares at Sep. 30, 2024	101,796,365		101,796,365